TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Taubert medicin AB
Closing information (x1000 NOK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
1,869
|
1,094
|
193 |
Financial expenses |
1
![]() |
1
|
0 |
Earnings before taxes |
131
|
34
|
-71 |
EBITDA |
131
|
35
|
-71 |
Total assets |
423
|
304
|
123 |
Current assets |
423
|
304
|
123 |
Current liabilities |
251
|
221
|
94 |
Equity capital |
166
|
65
|
29 |
- share capital |
50
|
52
|
48 |
Employees (average) |
2
![]() |
2
|
1 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
39.2%
|
21.4%
|
23.6% |
Turnover per employee |
934
|
547
|
193 |
Profit as a percentage of turnover |
7.0%
|
3.1%
|
-36.8% |
Return on assets (ROA) |
31.2%
|
11.5%
|
-57.7% |
Current ratio |
168.5%
|
137.6%
|
130.9% |
Return on equity (ROE) |
78.9%
|
52.3%
|
-244.8% |
Change turnover |
808
|
884
|
-67 |
Change turnover % |
76%
|
422%
|
-26% |
Chg. No. of employees |
0
|
1
![]() |
1 |
Chg. No. of employees % |
0%
|
100% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.